Aging drug pioneer Calico inks $1 billion extension of AbbVie deal
The seven-year research collaboration, which now will continue into 2025 and oversee clinical trials into 2030, has spun three neurodegenerative and cancer immunotherapy programs into the clinic. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 28, 2021 Category: Health Management Authors: Ron Leuty Source Type: news

FDA Grants Orphan Drug Designation to Novel Mesothelioma Treatment
The U.S. Food and Drug Administration has granted orphan drug designation to ONCOFID-P for the treatment of malignant pleural mesothelioma, a step toward another potential therapy option for patients. ONCOFID-P is an innovative drug conjugate already in advanced clinical development for the treatment of invasive bladder cancer. The mesothelioma designation is based on preclinical data showing high antitumor activity in laboratory and mice models. Fidia Farmaceutici, a multinational research company based in Italy, announced the latest FDA designation, which is designed to encourage the development of novel drugs, par...
Source: Asbestos and Mesothelioma News - July 28, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

FDA alerts patients and health care professionals about clinical trial results showing an increased risk of death associated with Pepaxto (melphalan flufenamide)
FDA alerts patients and health care professionals that a clinical trial evaluating Pepaxto (melphalan flufenamide) showed an increased risk of death. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 28, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Researcher Hopes to Improve Tumor Treating Fields for Mesothelioma
Dr. Maurizio D’Incalci already has seen Tumor Treating Fields working for patients with malignant pleural mesothelioma, and applauded the U.S. Food and Drug Administration’s approval of the treatment in 2019. He also knows the therapy is only scratching the surface of its vast potential and could be even more effective. He wants to help improve it. D’Incalci, a heralded biomedical science professor at Humanitas University in Milan, Italy, has begun a study exploring various drug combinations that could have a positive, synergistic effect with Tumor Treating Fields for mesothelioma. “There m...
Source: Asbestos and Mesothelioma News - July 27, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Home-use evaluation of a wearable collision warning device for individuals with severe vision impairments: a randomized clinical trial - Pundlik S, Baliutaviciute V, Moharrer M, Bowers AR, Luo G.
IMPORTANCE: There is scant rigorous evidence about the real-world mobility benefit of electronic mobility aids. OBJECTIVE: To evaluate the effect of a collision warning device on the number of contacts experienced by blind and visually impaired peo... (Source: SafetyLit)
Source: SafetyLit - July 27, 2021 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news

Many Pandemic-Driven Changes to Cancer CTs Should Remain Many Pandemic-Driven Changes to Cancer CTs Should Remain
Many of the changes made in the wake of the COVID-19 pandemic have made cancer clinical trials more patient centered and efficient, and should remain, say experts.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 27, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Covid US: Pfizer and Moderna expand vaccine clinical trials in children aged 5-11
Pfizer-BioNTech and Moderna are expanding the sizes of their COVID-19 vaccine clinical trials in children ages five to 11 at the urging of the U.S. Food and Drug Administration (FDA). (Source: the Mail online | Health)
Source: the Mail online | Health - July 26, 2021 Category: Consumer Health News Source Type: news

Does taking omega-3 supplements reduce the risk of having depression or anxiety? Probably not
Findings from observational studies have led to suggestions that dietary omega-3 supplementation can lower the risk of depression and anxiety; however, results of a recent meta-analysis of randomised trials prove otherwise. In a recent systematic review, the authors assessed the effect of omega-3 PUFA supplementation on the risk of anxiety and depression using evidence from randomised clinical trials (RCTs). Their primary outcome was the risk of depression or anxiety based on a formal diagnosis or use of an appropriate scale. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 26, 2021 Category: Consumer Health News Source Type: news

Africa: WHO Position Statement On Innovative Clinical Trial Designs for Development of New TB Treatments
[WHO] The World Health Organization is publishing a position statement on Innovative Clinical Trial Designs for Development of New TB Treatments. This document aims to support TB regimen development by highlighting key clinical trial characteristics to help advance novel therapies. It summarises key innovations in TB clinical trial designs, ranging from pharmacokinetic-pharmacodynamic (PK-PD) modelling and new advances in biomarker development to the value of novel clinical trial design methodologies and post-li (Source: AllAfrica News: Tuberculosis)
Source: AllAfrica News: Tuberculosis - July 26, 2021 Category: Infectious Diseases Source Type: news

Biden Officials Now Expect Vulnerable Americans to Need Booster Shots
The growing consensus that at least some Americans will need a booster is partly tied to research suggesting that Pfizer ’s vaccine is less effective after about six months. (Source: NYT Health)
Source: NYT Health - July 24, 2021 Category: Consumer Health News Authors: Sharon LaFraniere Tags: Vaccination and Immunization Coronavirus (2019-nCoV) Clinical Trials Centers for Disease Control and Prevention Food and Drug Administration Pfizer Inc Moderna Inc Johnson & Offit, Paul A Source Type: news

Brazil suspends clinical trials of Bharat Biotech's Covaxin
“The Coordination of Clinical Research at Anvisa (Copec/GGMED) determined this Friday (23/7) the precautionary suspension of clinical studies of the Covaxin vaccine in Brazil,”Anvisa, the Brazilian health regulator said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2021 Category: Pharmaceuticals Source Type: news

The Robot Comes to Mastectomy, But Cancer Outcomes Data Not Attached The Robot Comes to Mastectomy, But Cancer Outcomes Data Not Attached
A series of clinical trials of robotic mastectomy for the prevention and/or treatment of breast cancer have recently started in the US, but oncologic outcomes and randomized trial designs are not in the mix.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Peninsula biotech turns down $125M payout — gasp! — as it pushes on with late-stage eye drug trials
The move signaled the relative ease for some biotech companies seeking cash in a capital-intensive business as well as this company's progress in a handful of clinical trials. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 23, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Peninsula biotech turns down $125M payout — gasp! — as it pushes on with late-stage eye drug trials
The move signaled the relative ease for some biotech companies seeking cash in a capital-intensive business as well as this company's progress in a handful of clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 23, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Brain tumor research HQ to be built on St. Joseph's Phoenix campus
A nonprofit translational research program that focuses on early phase clinical trials to identify new treatments for aggressive brain tumors, such as glioblastoma — the cancer that killed Sen. John McCain — has big expansion plans for Phoenix. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 23, 2021 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

Brain tumor research HQ to be built on St. Joseph's Phoenix campus
A nonprofit translational research program that focuses on early phase clinical trials to identify new treatments for aggressive brain tumors, such as glioblastoma — the cancer that killed Sen. John McCain — has big expansion plans for Phoenix. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 23, 2021 Category: Biotechnology Authors: Angela Gonzales Source Type: news

Point Biopharma, Isotopia sign clinical agreement for isotope
Point Biopharma Global and Isotopia Molecular Imaging announced the companie...Read more on AuntMinnie.comRelated Reading: Isotopia backs development of 'virtual' biopsy Point Biopharma nets NRC OK to operate facility in Ind. Isotopia to supply MTTI with Lu-177 Avacta inks license agreement with Point Biopharma Point Biopharma to use Lantheus' PyL in clinical trial (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 23, 2021 Category: Radiology Source Type: news

How Laboratory Testing Supports Clinical Trials
Explore the importance of histology and biomarker evaluation for oncology clinical trials. (Source: The Scientist)
Source: The Scientist - July 23, 2021 Category: Science Tags: The Marketplace Source Type: news

Drug Shows Promise in Easing Dementia-Linked Psychosis
FRIDAY, July 23, 2021 -- A drug that eases hallucinations in people with Parkinson's disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 23, 2021 Category: General Medicine Source Type: news

Israeli company set to become world's first country to launch clinical trials of ORAL Covid vaccine
Oravax Medical's oral vaccine targets three proteins on the coronavirus rather then the single spike protein that the Pfizer-BioNTech and Moderna vaccines target. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2021 Category: Consumer Health News Source Type: news

Biden: Children Could Get COVID-19 Vaccine Within Months Biden: Children Could Get COVID-19 Vaccine Within Months
Pfizer and Moderna are conducting vaccine clinical trials for children ages 6 months to 12 years. Results are expected sometime this fall.WebMD Health News (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - July 22, 2021 Category: Pediatrics Tags: Infectious Diseases News Source Type: news

Cambridge microbiome startup's shares sliced in half after key trial failure
Microbiome startup Seres Therapeutics' shares are in a free fall after the company announced that its ulcerative colitis drug had failed in a mid-stage clinical trial. Seres (Nasdaq: MCRB) had been developing the drug in partnership with Nestlé Health Science as part of its suite of bacteria-based drugs, several of which are in clinical development. The ulcerative colitis study will be shut down, as the drug resulted in "no meaningful clinical differences" in a placebo comparison trial involving… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 22, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports
Abstract Objectives To study the extent of blinding in randomised clinical trials of psychological interventions and the interpretative considerations if randomised clinical trials are not blinded. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 22, 2021 Category: Consumer Health News Source Type: news

Should Changes Made to Clinical Trials During Pandemic Be Kept?
THURSDAY, July 22, 2021 -- Many of the alterations made to clinical trial procedures during the COVID-19 pandemic should be implemented in the post-COVID-19 roadmap, according to an article published online July 21 in Cancer Discovery. Keith T.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2021 Category: Pharmaceuticals Source Type: news

CAR T-Cell Therapy Showing Promise with Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center continues its drive toward a future that may involve innovative CAR T-cell therapy as part of standard-of-care treatment for malignant pleural mesothelioma. The latest step was a clinical trial exploring a first-in-human, intrapleural-administered CAR T-cell therapy used in combination with pembrolizumab, a well-known immunotherapy drug also known by the brand name Keytruda. Results were impressive, including a 23.9-month median overall survival and an 83% one-year survival rate for patients. Cancer Discovery published the single-center study results July 15. “There is ...
Source: Asbestos and Mesothelioma News - July 22, 2021 Category: Environmental Health Authors: Chris Elkins Source Type: news

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa
(UNC Lineberger Comprehensive Cancer Center) Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

PureTech spinout Vedanta brings in $68M for microbiome drugs
Vedanta Biosciences, the microbiome startup founded and incubated by Daphne Zohar's PureTech Health, has raised $68 million to propel its bacteria-based drug candidates into late-stage clinical trials. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 21, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

New Drug Combination Shows Promise for Peritoneal Mesothelioma
Researchers at MD Anderson Cancer Center in Houston have uncovered a new, promising treatment option for patients with peritoneal mesothelioma, potentially filling a gaping void that exists today. The immunotherapy drug combination of Tecentriq and Avastin, known generically as atezolizumab and bevacizumab, respectively, showed unusual efficacy in a recent study of 20 patients with this rare cancer. Although some patients have previously found significant success and extended survival with the cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combination, or HIPEC, those with unresectable disease ha...
Source: Asbestos and Mesothelioma News - July 21, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Media News - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Investor Update - July 21, 2021 Category: Pharmaceuticals Source Type: news

Precision treatment for severe asthma targets a specific mutation
(Boston Children's Hospital) Under a $10 million NIH grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable. The four-center trial follows a half-decade of research at the hospital showing how a mutation in the gene ILR4 causes severe, hard-to-treat asthma -- and the potential for an existing drug to counter it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Novel method predicts if COVID-19 clinical trials will fail or succeed
(Florida Atlantic University) Researchers are the first to model COVID-19 completion versus cessation in clinical trials using machine learning algorithms and ensemble learning. They collected 4,441 COVID-19 trials from ClinicalTrials.gov to build a testbed with 693 dimensional features created to represent each clinical trial. These computational methods can predict whether a COVID-19 clinical trial will be completed or terminated, withdrawn or suspended. Stakeholders can leverage the predictions to plan resources, reduce costs, and minimize the time of the clinical study. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Evidence of sustained benefits of pimavanserin for dementia-related psychosis
(University of Exeter) A new paper published in the New England Journal of Medicine outlines a clinical trial, conducted in 392 people with psychosis associated with Alzheimer's disease, Parkinson's disease, Lewy body, frontotemporal, or vascular dementia. All participants were given pimavanserin for 12 weeks. Those who met a threshold of symptom improvement were then assigned to pimavanserin or placebo for up to 26 weeks. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

An Internet-based emotion regulation intervention versus no intervention for non-suicidal self-injury in adolescents: a statistical analysis plan for a feasibility randomised clinical trial - Olsen MH, Morthorst B, Pagsberg AK, Heinrichsen M, M øhl B, Rubæk L, Bjureberg J, Simonsson O, Lindschou J, Gluud C, Jakobsen JC.
BACKGROUND: Non-suicidal self-injury (NSSI) has a lifetime prevalence of 17% in adolescents in the general population and up to 74% in adolescents with psychiatric disorders. NSSI is one of the most important predictors of later suicidal behaviour and deat... (Source: SafetyLit)
Source: SafetyLit - July 21, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Monoclonal antibodies help COVID-19 patients avoid hospitalization
ROCHESTER, Minn. ― In a large observational study, Mayo Clinic researchers have shown that two monoclonal antibodies administered separately helped prevent hospitalization in high-risk patients who became infected with COVID-19. The study also showed more hospitalizations were observed among patients with more com orbidities. The findings appear in The Journal of Infectious Diseases. "The real-world data reported in this study confirm what has been seen in clinical trials involving a placebo," says Raymund Razonable, M.D., a… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 21, 2021 Category: Databases & Libraries Source Type: news

How Aduhelm, an Unproven Alzheimer ’s Drug, Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen ’s Aduhelm, or aducanumab. (Source: NYT Health)
Source: NYT Health - July 20, 2021 Category: Consumer Health News Authors: Pam Belluck, Sheila Kaplan and Rebecca Robbins Tags: Aduhelm (Drug) Alzheimer ' s Disease Food and Drug Administration Drugs (Pharmaceuticals) Labeling and Labels (Product) Clinical Trials Elderly Science and Technology Regulation and Deregulation of Industry Research Brain Biogen Source Type: news

New FDA Guidance on T2D Trial Design Provides Flexibility New FDA Guidance on T2D Trial Design Provides Flexibility
The FDA released new draft guidance for the evaluation of type 2 diabetes drugs. Dr John Buse discusses the impact this could have on clinical trials and the medications we might see from the changes.Medscape Diabetes & Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology Commentary Source Type: news

Undone Proteins Take Out Bladder Cancer
An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer. (Source: The Scientist)
Source: The Scientist - July 20, 2021 Category: Science Tags: Sponsored Article Source Type: news

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa
(International Vaccine Institute) The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding of up to $12.7m to the Expanding Access and Delivery of COVID-19 Vaccines in Africa (ECOVA) consortium led by IVI to carry out clinical trials of Sinopharm's BBIBP-CorV vaccine which will support the expanded use of the vaccine on the African continent. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 20, 2021 Category: Infectious Diseases Source Type: news

Digital health technologies hold key to new Parkinson's treatments
(Critical Path Institute (C-Path)) The use of digital health technologies across health care and drug development has accelerated. A new paper titled " Digital Progression Biomarkers as Novel Endpoints in Clinical Trials: A Multistakeholder Perspective, " co-authored by experts across diverse disciplines, highlights how new remote monitoring technologies present a tremendous opportunity to advance digital medicine in health care even further, specifically in Parkinson's disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2021 Category: International Medicine & Public Health Source Type: news

Research shows employer-based weight management program with access to anti-obesity medications results in greater weight loss
(Cleveland Clinic) Research Shows Employer-Based Weight Management Program With Access To Anti-Obesity Medications Results in Greater Weight Loss Clinical trial was conducted in the real-world setting of a workplace health plan A Cleveland Clinic study demonstrates that adults with obesity lost significantly more weight when they had access to medications for chronic weight management in conjunction with their employer-based weight management program, compared to adults who did not have access to the medications. The study was published in JAMA Network Open. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2021 Category: International Medicine & Public Health Source Type: news

How an Unproven Alzheimer ’s Drug Got Approved
Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen ’s Aduhelm, or aducanumab. (Source: NYT Health)
Source: NYT Health - July 20, 2021 Category: Consumer Health News Authors: Pam Belluck, Sheila Kaplan and Rebecca Robbins Tags: Aduhelm (Drug) Alzheimer ' s Disease Food and Drug Administration Drugs (Pharmaceuticals) Labeling and Labels (Product) Clinical Trials Elderly Science and Technology Regulation and Deregulation of Industry Research Brain Biogen Source Type: news

4 Covid vaccine candidates in human trial stage, 1 in pre-clinical stage, govt tells Rajya Sabha
In a written response to a question in the Rajya Sabha, Union Science and Technology Minister Jitendra Singh said Cadila Healthcare Ltd's DNA-based vaccine candidate is in phase three clinical trial. It has also submitted the interim data for emergency use authorisation. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2021 Category: Pharmaceuticals Source Type: news

Longtime Peninsula biotech seeks $200M as stock soars on strength of heart drug trial
The company's stock soared more than 40% Monday as it said it will take a heart drug into a late-stage clinical trial. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 19, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Longtime Peninsula biotech seeks $200M as stock soars on strength of heart drug trial
The company's stock soared more than 40% Monday as it said it will take a heart drug into a late-stage clinical trial. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - July 19, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Covid's Beta Variant: Here's What We Know
The variant can dodge some of the immune system ’s defenses, but is still vulnerable to vaccines. (Source: NYT Health)
Source: NYT Health - July 19, 2021 Category: Consumer Health News Authors: Emily Anthes Tags: Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) your-feed-science your-feed-healthcare South Africa England Source Type: news

Is the new "morning after pill" a Covid vaccine?
(Natural News) There are now three ways of ending a pregnancy: in-clinic abortion, the abortion pill, or a Covid vaccine. All China Flu vaccines are free and available without a prescription, and have now been proven in a clinical trial to kill 4 out of every 5 babies in the womb during the first two... (Source: NaturalNews.com)
Source: NaturalNews.com - July 19, 2021 Category: Consumer Health News Source Type: news

UK trial aims to find hidden lung damage caused by long Covid
Study is part of £20m research drive that scientists hope will end stigma around the conditionCoronavirus – latest updatesSee all our coronavirus coverageA clinical trial has been launched to detect currently invisible lung damage in people withlong Covid, as part of a £20m research drive that scientists hope will end stigma around the condition.Patients still suffering breathlessness will be drawn from long Covid clinics in Sheffield, Manchester and Cardiff to undergo special scans using xenon gas to reveal damage that does not show up on conventional CT scans, leading to a mystery about why people are n...
Source: Guardian Unlimited Science - July 17, 2021 Category: Science Authors: Robert Booth Social affairs correspondent Tags: Coronavirus Medical research UK news Health Sheffield Manchester Cardiff Source Type: news

A randomized clinical trial of cognitive-behavioral therapy for insomnia to augment posttraumatic stress disorder treatment in survivors of interpersonal violence - Pigeon WR, Crean HF, Cerulli C, Gallegos AM, Bishop TM, Heffner KL.
INTRODUCTION: Individuals exposed to interpersonal violence (IPV) commonly develop posttraumatic stress disorder (PTSD) with co-occurring depression and insomnia. Standard PTSD interventions such as cognitive processing therapy (CPT) do not typically lead ... (Source: SafetyLit)
Source: SafetyLit - July 17, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Acid Suppression Medications During Hospitalization as a Risk Factor for Recurrence of Clostridioides difficile Infection: Systematic Review and Meta-analysis
Conclusions: ASM use during hospitalization was associated with a 64% increase in recurrent CDI. The association was greater with PPI use. Due to significant heterogeneity in the analyses, additional studies are essential to further elucidate iatrogenic effects of ASM. Unnecessary PPI use should be discontinued. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 16, 2021 Category: Consumer Health News Source Type: news